Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.
作者信息
Bittencourt Rosane, Bortolheiro Teresa Cristina, de Lourdes Lopes Ferrari Chauffaille Maria, Fagundes Evandro Maranhão, Pagnano Katia Borgia Barbosa, Rego Eduardo Magalhães, Bernardo Wanderley Marques
机构信息
Universidade Federal do Rio Grande do Sul (UFGRS), Porto Alegre, RS, Brazil.
Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil.
出版信息
Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):58-74. doi: 10.1016/j.bjhh.2016.01.001. Epub 2016 Feb 5.
Abstract
摘要
相似文献
1
Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.急性髓系白血病治疗指南：巴西血液学、血液疗法和细胞治疗协会：项目指南：巴西医学协会 - 2015年
Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):58-74. doi: 10.1016/j.bjhh.2016.01.001. Epub 2016 Feb 5.
2
Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013.急性早幼粒细胞白血病诊断与治疗指南：巴西血液学、血液疗法与细胞治疗协会指南项目：巴西医学协会 - 2013年
Rev Bras Hematol Hemoter. 2014;36(1):71-92. doi: 10.5581/1516-8484.20140018.
3
Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.成人免疫性血小板减少症指南：巴西血液学、血液治疗与细胞治疗协会。项目指南：巴西医学协会 - 2018年。
Hematol Transfus Cell Ther. 2018 Jan-Mar;40(1):50-74. doi: 10.1016/j.htct.2017.11.001. Epub 2018 Feb 17.
4
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.多发性骨髓瘤治疗的诊断与管理指南：巴西血液学、血液疗法及细胞治疗协会项目指南：巴西医学协会 - 2012年版
Rev Bras Hematol Hemoter. 2013;35(3):201-17. doi: 10.5581/1516-8484.20130050.
5
Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.使用重组人促红细胞生成素治疗慢性肾衰竭贫血的指南：巴西血液学、血液疗法及细胞治疗协会指南项目：巴西医学协会 - 2014年
Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):450-3. doi: 10.1016/j.bjhh.2014.09.009. Epub 2014 Oct 1.
6
Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.儿童和青少年原发性免疫性血小板减少症治疗指南：巴西血液学、血液治疗与细胞治疗协会指南项目：巴西医学协会 - 2012年
Rev Bras Hematol Hemoter. 2013;35(6):417-27. doi: 10.5581/1516-8484.20130124.
7
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.多发性骨髓瘤治疗的诊断与管理指南：巴西血液学、血液治疗与细胞治疗协会项目指南：巴西医学协会 - 2022年。第一部分。
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20.
8
Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.儿童和青少年原发性免疫性血小板减少症诊断指南：巴西血液学、血液治疗和细胞治疗协会指南项目：巴西医学协会 - 2012年。
Rev Bras Hematol Hemoter. 2013;35(5):358-65. doi: 10.5581/1516-8484.20130105.
9
Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016.重型β地中海贫血定期输血治疗指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2016年。
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):341-345. doi: 10.1016/j.bjhh.2016.09.003. Epub 2016 Sep 22.
10
Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.镰状细胞病新生儿筛查与疼痛性血管闭塞危象指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2016年
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):147-57. doi: 10.1016/j.bjhh.2016.04.001. Epub 2016 Apr 8.
引用本文的文献
1
Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells.姜黄根茎中的可食用姜黄素与化疗药物联合治疗对白血病干细胞的细胞毒性和 FLT3 蛋白表达的影响。
Molecules. 2021 Sep 24;26(19):5785. doi: 10.3390/molecules26195785.
2
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.挽救治疗难治或复发急性髓系白血病：10 年单中心经验。
Clinics (Sao Paulo). 2020 Apr 6;75:e1566. doi: 10.6061/clinics/2020/e1566. eCollection 2020.
3
Current treatment preferences in acute myeloid leukemia: a survey in Brazil.巴西急性髓系白血病的当前治疗偏好：一项调查
Hematol Transfus Cell Ther. 2020 Jul-Sep;42(3):252-254. doi: 10.1016/j.htct.2019.07.005. Epub 2019 Sep 11.
本文引用的文献
1
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin.通过WT1和NPM1转录水平评估的微小残留病（MRD）可识别急性髓系白血病（AML）患者的不同预后，并且受吉妥珠单抗奥唑米星影响。
Oncotarget. 2014 Aug 15;5(15):6280-8. doi: 10.18632/oncotarget.2196.
2
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中复发和生存的联合分子和临床预后指数。
J Clin Oncol. 2014 May 20;32(15):1586-94. doi: 10.1200/JCO.2013.52.3480. Epub 2014 Apr 7.
3
The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia.全反式维甲酸联合化疗可能无法改善 NPM1 突变型急性髓系白血病患者的预后。
Front Oncol. 2013 Sep 6;3:218. doi: 10.3389/fonc.2013.00218. eCollection 2013.
4
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.核型正常急性髓细胞白血病患者中根据 NPM1/FLT3-ITD 分子状态进行自体造血干细胞移植的作用：GOELAMS 研究。
Am J Hematol. 2012 Dec;87(12):1052-6. doi: 10.1002/ajh.23311. Epub 2012 Aug 22.
5
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial.定量 RT-PCR 检测核心结合因子 AML 中的微小残留病可进行风险分层并预测复发：英国 MRC AML-15 试验的结果。
Blood. 2012 Oct 4;120(14):2826-35. doi: 10.1182/blood-2012-06-435669. Epub 2012 Aug 8.
6
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.急性髓系白血病中综合基因分析的预后相关性。
N Engl J Med. 2012 Mar 22;366(12):1079-89. doi: 10.1056/NEJMoa1112304. Epub 2012 Mar 14.
7
A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.一项比较标准剂量与高剂量柔红霉素诱导治疗急性髓系白血病患者的随机试验。
Blood. 2011 Oct 6;118(14):3832-41. doi: 10.1182/blood-2011-06-361410. Epub 2011 Aug 9.
8
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.高剂量阿糖胞苷与时间序列化疗作为首次缓解的年轻 AML 患者巩固治疗的比较：ALFA-9802 研究。
Blood. 2011 Aug 18;118(7):1754-62. doi: 10.1182/blood-2011-04-349258. Epub 2011 Jun 20.
9
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.在急性髓细胞白血病首次强化治疗中，阿糖胞苷剂量 36g/m² 与 12g/m² 比较：前瞻性随机 AML96 研究入组患者的结果。
J Clin Oncol. 2011 Jul 1;29(19):2696-702. doi: 10.1200/JCO.2010.33.7303. Epub 2011 May 23.
10
Cytarabine dose for acute myeloid leukemia.阿糖胞苷剂量治疗急性髓系白血病。
N Engl J Med. 2011 Mar 17;364(11):1027-36. doi: 10.1056/NEJMoa1010222.
Zotero 插件